ReviewDiabetes & vascular disease research2014

The effects of GLP-1 analogues, DPP-4 inhibitors and SGLT2 inhibitors on the renal system.

Guntram Schernthaner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.